Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin

Figure 6

The ex vivo optical images of the intestines and organs of 6–8-week-old BALB/c mice with oral administration of Cy7-labeled fluorescent sublancin at 12 h. Monitor of the Cy7-labeled sublancin in the excised intestines (a) and organs (c); monitor of the free Cy7 in the excised intestines (b) and organs (d).